Search Result "darolutamide"


Research Article

Pharmacokinetics of Darolutamide in Mouse - Assessment of the Disposition of the Diastereomers, Key Active Metabolite and Interconversion Phenomenon: Implications to Cancer Patients

Journal: Drug Metabolism Letters
Volume: 14 Issue: 1 Year: 2021 Page: 54-65
Author(s): Neeraj K. Saini,Bhavesh B. Gabani,Umesh Todmal,Suresh P. Sulochana,Vinay Kiran,Mohd. Zainuddin,Narayanan Balaji,Sai B. Polina,Nuggehally R. Srinivas,Ramesh Mullangi

Letter Article open access plus

Pharmacokinetics of Darolutamide, its Diastereomers and Active Metabolite in the Mouse: Response to Saini NK et al. (2020)

Journal: Drug Metabolism Letters
Volume: 14 Issue: 1 Year: 2021 Page: 9-16
Author(s): Pirjo Nykänen,Timo Korjamo,Hille Gieschen,Christian Zurth,Mikko Koskinen

Review Article

Darolutamide as a Second-Generation Androgen Receptor Inhibitor in the Treatment of Prostate Cancer

Journal: Current Molecular Medicine
Volume: 21 Issue: 4 Year: 2021 Page: 332-346
Author(s): Ali Abbasi,Ahmad Movahedpour,Ahmad Amiri,Mohamad Samare Najaf,Zohreh Mostafavi-Pour

General Review Article

Recent Development and Future Prospects of Molecular TargetedTherapy in Prostate Cancer

Journal: Current Molecular Pharmacology
Volume: 15 Issue: 1 Year: 2022 Page: 159-169
Author(s): Jinku Zhang,Jirui Sun,Sahar Bakht,Waseem Hassan

Review Article

An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs(2018-2021)

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 24 Issue: 8 Year: 2024 Page: 590-626
Author(s):

Perspective

Combination Therapy with Androgen Receptor Pathway Inhibitors forProstate Cancer

Journal: Current Cancer Drug Targets
Volume: 23 Issue: 6 Year: 2023 Page: 428-432
Author(s):

Ga-PSMA PET/CT for Patients with Prostate Cancer with PSA Relapse

Ebook: The Evolution of Radionanotargeting towards Clinical Precision Oncology: A Festschrift in Honor of Kalevi Kairemo

Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9781681088655122010017
Research Article

Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 1 Year: 2020 Page: 84-93
Author(s): Sasikumar Andavar,Mohanasrinivasan Vaithilingam,Divakar Selvaraj,Ajeeshkumar A. Kumaran,Krishnaswamy Devanathan

Review Article

Nanoparticles Mediated Target-specific Drug Delivery in ProstateCancer: An In-depth Review

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 2 Year: 2022 Page: 4170-4184
Author(s): Tarun Kumar Upadhyay,Mohammed Irfan Ali,Fahad Khan,Harsh Goel,Manas Mathur,Keshav Goyal,Sarmad Moin,Pratibha Pandey,Pranay Tanwar,Amit Baran Sharangi,Saloni Dinesh Chandra Gautam,Jhanvi Kiran Kapdi,Kruti Indravadan Patel,Meghna Vipulbhai Patel,Amisha M. Parmar,Mohammad Amjad Kamal

Nanocarrier-based Targeted Delivery in Cancer

Ebook: Nanoparticles and Nanocarriers-Based Pharmaceutical Formulations

Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815049787122010010

Previous   Next

Go To   Results 1 - 1 of 13

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy